Slater Sentinel logo

The Latest Headlines at Slater Sentinel

Image about NRx Pharmaceuticals (NASDAQ:NRXP) Shares Set to Reverse Split on Tuesday, April 2nd

NRx Pharmaceuticals (NASDAQ:NRXP) Shares Set to Reverse Split on Tuesday, April 2nd

Shares of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP – Free Report) are set to reverse split on the morning of Tuesday, April 2nd. The 1-10 reverse split was announced on Tuesday, April 2nd. The number of shares owned by shareholders... More of this article »
Image about StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note issued to investors on Tuesday. The firm issued a hold rating on the stock. TherapeuticsMD Trading Up 1.8 % Shares of TherapeuticsMD... More of this article »
Image about M.D.C. (NYSE:MDC) Now Covered by StockNews.com

M.D.C. (NYSE:MDC) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of M.D.C. (NYSE:MDC – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the construction company’s stock. MDC has been the topic... More of this article »
Image about Kaman (NYSE:KAMN) Earns Buy Rating from Analysts at StockNews.com

Kaman (NYSE:KAMN) Earns Buy Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Kaman (NYSE:KAMN – Free Report) in a report released on Tuesday morning. The firm issued a buy rating on the industrial products company’s stock. Separately, TheStreet upgraded... More of this article »
Image about HC Wainwright Reaffirms “Buy” Rating for Genprex (NASDAQ:GNPX)

HC Wainwright Reaffirms “Buy” Rating for Genprex (NASDAQ:GNPX)

HC Wainwright reaffirmed their buy rating on shares of Genprex (NASDAQ:GNPX – Free Report) in a research report report published on Monday morning, MarketBeat reports. The brokerage currently has a $10.00 price target on the... More of this article »
Image about Lyra Therapeutics (NASDAQ:LYRA) Price Target Cut to $11.00 by Analysts at Bank of America

Lyra Therapeutics (NASDAQ:LYRA) Price Target Cut to $11.00 by Analysts at Bank of America

Lyra Therapeutics (NASDAQ:LYRA – Free Report) had its target price trimmed by Bank of America from $12.00 to $11.00 in a report issued on Monday morning, Benzinga reports. The firm currently has a buy rating on the stock. Several... More of this article »
Image about Masimo (NASDAQ:MASI) Price Target Increased to $148.00 by Analysts at Stifel Nicolaus

Masimo (NASDAQ:MASI) Price Target Increased to $148.00 by Analysts at Stifel Nicolaus

Masimo (NASDAQ:MASI – Free Report) had its price target raised by Stifel Nicolaus from $125.00 to $148.00 in a research note published on Monday morning, Benzinga reports. Stifel Nicolaus currently has a hold rating on the medical... More of this article »
Image about Rockwell Medical (NASDAQ:RMTI) Given New $9.00 Price Target at HC Wainwright

Rockwell Medical (NASDAQ:RMTI) Given New $9.00 Price Target at HC Wainwright

Rockwell Medical (NASDAQ:RMTI – Free Report) had its price objective lowered by HC Wainwright from $11.00 to $9.00 in a report released on Monday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock.... More of this article »
Image about Li Auto (NASDAQ:LI) PT Lowered to $65.00

Li Auto (NASDAQ:LI) PT Lowered to $65.00

Li Auto (NASDAQ:LI – Free Report) had its price target decreased by Morgan Stanley from $74.00 to $65.00 in a report released on Monday morning, Benzinga reports. Morgan Stanley currently has an overweight rating on the stock. Several... More of this article »
Image about Altria Group (NYSE:MO) Given “Buy” Rating at Stifel Nicolaus

Altria Group (NYSE:MO) Given “Buy” Rating at Stifel Nicolaus

Stifel Nicolaus restated their buy rating on shares of Altria Group (NYSE:MO – Free Report) in a research note issued to investors on Monday, Benzinga reports. Stifel Nicolaus currently has a $50.00 price target on the stock. A... More of this article »
Image about Microsoft (NASDAQ:MSFT) Rating Reiterated by Truist Financial

Microsoft (NASDAQ:MSFT) Rating Reiterated by Truist Financial

Truist Financial restated their buy rating on shares of Microsoft (NASDAQ:MSFT – Free Report) in a research report sent to investors on Monday morning, Benzinga reports. They currently have a $600.00 price target on the software... More of this article »
Image about SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) Given Consensus Rating of “Moderate Buy” by Analysts

SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) Given Consensus Rating of “Moderate Buy” by Analysts

SS&C Technologies Holdings, Inc. (NASDAQ:SSNC – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the company, MarketBeat reports. Two analysts... More of this article »
Image about PowerSchool Holdings, Inc. (NYSE:PWSC) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

PowerSchool Holdings, Inc. (NYSE:PWSC) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of PowerSchool Holdings, Inc. (NYSE:PWSC – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten research firms that are covering the firm, Marketbeat reports. One research... More of this article »
Image about The Toro Company (NYSE:TTC) Receives Consensus Recommendation of “Hold” from Brokerages

The Toro Company (NYSE:TTC) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of The Toro Company (NYSE:TTC – Get Free Report) have been assigned an average rating of “Hold” from the five brokerages that are covering the stock, MarketBeat Ratings reports. Three investment analysts have... More of this article »
Image about Jacobs Solutions Inc. (NYSE:J) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Jacobs Solutions Inc. (NYSE:J) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Jacobs Solutions Inc. (NYSE:J – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eleven research firms that are covering the company, Marketbeat.com reports. Four analysts have rated... More of this article »